Reform

---

“Navigating the FDA’s Shifting Stance on Cannabis & Psychedelics”

• The shifting landscape of cannabis and psychedelics is propelled by advancing research and changing societal perspectives. Recent discussions indicate that federal legalization of psychedelics may precede that of cannabis in the United States, primarily due to the FDA’s challenge in regulating the diverse therapeutic compounds within cannabis compared to single molecules in psychedelics.

“Legalizing Marijuana, Psilocybin Mushrooms, and MDMA for Medical Use“

• Understanding a nation’s drug history illuminates the shifts in policy over time. Currently, federal policies, including the DEA’s scheduling and military regulations, hinder the legalization of medical marijuana, psilocybin mushrooms, and MDMA for federal employees and veterans despite growing evidence of their therapeutic benefits.

“What Is the Current Legal Landscape of the Psychedelics Industry”

• Psychedelics is an industry amid a revolution. Research, public perception, and even regulations are shifting at an incredible pace, paving the way for a nascent industry to rise in a matter of years. During such change, it can be easy to lose track of where we currently are, not where we’ll be in six months, one year, or five years.  

Understanding Ketamine’s Controlled Substance Status:

What It Means for Healthcare Providers

As ketamine gains recognition for its potential in treating conditions like treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD), and chronic pain, it’s essential for healthcare providers to understand its regulatory classification. Ketamine’s classification as a Schedule III controlled substance under the U.S. Controlled Substances Act carries significant legal and clinical implications. In this post, we’ll explore what this controlled status means for healthcare professionals, including prescribing, administration, and compliance with federal and state regulations.

What Does Schedule III Classification Mean?

Ketamine’s Schedule III designation reflects its medical value but also a moderate potential for abuse. This classification positions ketamine between Schedule I and II drugs (which have high abuse potential and are more strictly regulated) and Schedule IV and V drugs (which have lower potential for misuse).

Key features of a Schedule III drug like ketamine include:

– Accepted Medical Use: Ketamine is widely used as an anesthetic, and more recently, its off-label use for treating mental health conditions and chronic pain has become common. While the FDA approved esketamine (Spravato), a derivative of ketamine, for treatment-resistant depression, IV ketamine therapy remains an off-label but effective intervention for many.

– Moderate Risk of Abuse and Dependence: Ketamine has a lower risk of abuse compared to drugs in higher schedules (like opioids), but its dissociative and hallucinogenic effects make it a target for recreational misuse. This risk necessitates stricter controls on prescribing, dispensing, and administering ketamine.

Prescription and Administration: What Healthcare Providers Need to Know

As a Schedule III drug, ketamine is subject to specific federal and state regulations. Healthcare providers must adhere to these guidelines to ensure compliance and patient safety.

1. DEA Registration and Licensing Requirements

To prescribe and administer ketamine, healthcare providers must be registered with the Drug Enforcement Administration (DEA). This DEA registration allows providers to handle controlled substances, and it is mandatory for physicians, nurse practitioners, and other qualified healthcare professionals involved in ketamine therapy.

– Obtaining a DEA License: If you’re planning to offer ketamine therapy, ensure that you have an active DEA license that permits the prescribing and handling of Schedule III substances.

– State-Level Requirements: Some states may impose additional requirements or restrictions on providers who prescribe or administer ketamine. It is crucial to check state-specific laws to ensure full compliance with local regulations.

 2. Prescription Guidelines and Limitations

When prescribing ketamine, healthcare providers must follow specific guidelines, including the circumstances under which ketamine is used and how it is documented.

– Medical Indications: Although ketamine is FDA-approved as an anesthetic, its use for depression, PTSD, or chronic pain is typically off-label. Providers should clearly document the medical rationale for off-label use and ensure patients are fully informed about the treatment.

  – Controlled Dosing: As ketamine is associated with risks of dissociation and misuse, careful attention must be given to dosing. For intravenous (IV) ketamine treatments, dosing typically begins at sub-anesthetic levels, and patients must be closely monitored throughout the session.

– Electronic Prescriptions: Many states now require that prescriptions for controlled substances, including ketamine, be electronically transmitted to prevent diversion and abuse. Ensure that your practice is equipped with an electronic prescription system that complies with DEA regulations.

3. Monitoring and Administration Requirements

Due to ketamine’s psychoactive effects, its administration often requires enhanced patient monitoring to ensure safety and manage side effects.

– In-Clinic Administration: In most cases, ketamine therapy, particularly for mental health conditions, is administered in a controlled clinical setting. Healthcare professionals must be present to monitor for acute side effects like dissociation, nausea, and altered blood pressure.

  – Patient Observation: Ketamine’s effects can vary widely among patients. Immediate monitoring is essential to manage potential dissociative episodes, hallucinations, or cardiovascular changes. This may involve pulse oximetry, blood pressure monitoring, and trained staff available for support.

– Controlled Substance Log: Like all controlled substances, ketamine must be tracked and logged accurately. Maintain comprehensive records of every dose administered, including details of the patient, dosage, time, and outcome, as required by the DEA.

4. Preventing Diversion and Abuse

Ketamine has a history of recreational use, so it is critical for healthcare providers to implement safeguards against diversion.

– Secure Storage: All ketamine products must be securely stored in a locked environment that complies with DEA storage regulations for Schedule III substances. Unauthorized access should be strictly limited.

  – Preventing Abuse: Educate patients about the risks of recreational ketamine use and the importance of following medical advice. Providers must screen patients for a history of substance abuse to assess whether they are at heightened risk for misuse.

– Monitoring for Diversion: Be vigilant for signs of ketamine misuse or diversion among patients. This may involve reviewing prescription histories, using Prescription Drug Monitoring Programs (PDMPs), and requiring follow-up visits to assess ongoing need and treatment efficacy.

 5. Legal and Ethical Considerations

Healthcare providers who offer ketamine therapy must be aware of the legal and ethical implications surrounding its use.

– Informed Consent: Given the off-label nature of IV ketamine for depression and other conditions, providers must obtain detailed informed consent from patients. This should include discussions about the experimental nature of the treatment, potential side effects, and risks.

  – Ethical Practice: As ketamine treatment for depression and chronic pain grows in popularity, so does the number of ketamine clinics. Providers should ensure that their practice aligns with established ethical standards and avoid misleading patients about the efficacy of ketamine therapy.

– Regulatory Compliance: Regularly audit your practice to ensure compliance with all federal and state regulations related to ketamine use. This may include periodic reviews of storage practices, patient records, and staff training protocols.

Conclusion

Ketamine’s Schedule III controlled substance status adds a layer of complexity to its administration in clinical settings. For healthcare providers, this means not only securing the proper licenses and registrations but also adhering to strict prescription, administration, and monitoring guidelines. By staying informed about ketamine’s regulatory framework, providers can offer this promising treatment safely and ethically, helping patients achieve relief while minimizing risks.

Understanding the responsibilities that come with prescribing and administering ketamine is key to ensuring both compliance and the delivery of high-quality care. Stay up to date on DEA requirements, state regulations, and evolving clinical best practices to support safe and effective ketamine therapy for your patients.

Understanding Ketamine’s Controlled Substance Status:

What It Means for Patients

Ketamine, once primarily known as an anesthetic, has emerged as a promising treatment for conditions like treatment-resistant depression, chronic pain, and PTSD. While its medical potential is exciting, ketamine is also a controlled substance in the U.S., which means its use is heavily regulated. In this blog post, we’ll break down what it means that ketamine is classified as a Schedule III drug under the U.S. Controlled Substances Act, and how this impacts its prescription and administration.

What is a Controlled Substance?

A controlled substance is a drug or chemical whose manufacture, possession, or use is regulated by the government due to its potential for abuse or addiction. Controlled substances are categorized into five “schedules” based on their accepted medical use and the risk of abuse or dependency. Schedule I drugs are considered the most dangerous and have no accepted medical use (like heroin), while Schedule V drugs have a lower potential for abuse and accepted medical uses.

What Does It Mean That Ketamine is a Schedule III Drug?

Ketamine is classified as a Schedule III drug. This means:

– Medical Use: Ketamine has accepted medical uses, primarily as an anesthetic. More recently, it has also been used off-label to treat mental health conditions like depression and PTSD.

– Moderate Abuse Potential: While ketamine has legitimate medical applications, it also carries a moderate risk of abuse and dependence. Recreational use of ketamine, often referred to as “Special K,” has been linked to dissociative experiences and hallucinations. As a result, the government regulates its use to prevent misuse.

– Stricter Regulations: Because of its Schedule III status, ketamine is subject to stricter controls compared to non-controlled medications. This affects how it can be prescribed, administered, and monitored in medical settings.

Who Can Prescribe and Administer Ketamine?

Given its controlled status, not just anyone can prescribe or administer ketamine. There are specific prescription and administration limits to ensure it is used safely:

1. Licensed Healthcare Providers: Only licensed healthcare professionals, such as doctors, nurse practitioners, and certain specialists, can prescribe ketamine. These providers must have a DEA (Drug Enforcement Administration) registration that allows them to prescribe controlled substances.

2. Medical Guidelines: Ketamine must be used in accordance with established medical guidelines. For example, ketamine is often administered intravenously (through an IV) or as a nasal spray (in the case of esketamine, a related drug). The dosing and monitoring are carefully controlled to ensure patient safety.

3. In-Clinic Use: For certain treatments, such as those for mental health, ketamine is typically administered in a clinic or hospital setting. This allows healthcare professionals to closely monitor patients for side effects and ensure the drug is used appropriately. While at-home use is possible in some cases (e.g., oral ketamine), it is still regulated and monitored to minimize risks.

Why Are These Regulations Important?

Ketamine’s classification as a Schedule III drug and the associated regulations serves two main purposes:

– Patient Safety: Ketamine can cause dissociation (a feeling of detachment from reality), hallucinations, and other side effects. When administered in a medical setting under the supervision of trained professionals, the risks can be minimized. Strict guidelines ensure that the drug is used safely and effectively.

– Preventing Abuse: Because of its potential for recreational use and abuse, ketamine’s-controlled status helps prevent misuse. By limiting access to licensed providers and requiring careful documentation and monitoring, regulators aim to reduce the chances of ketamine being diverted for non-medical use.

What Does This Mean for Patients Seeking Ketamine Treatment?

If you are considering ketamine treatment for a medical condition like depression, chronic pain, or PTSD, here’s what you need to know:

– You Need a Prescription: Ketamine cannot be bought over-the-counter or obtained without a prescription. You will need to consult with a licensed healthcare provider who is trained in administering ketamine and who can evaluate whether it’s the right treatment for you.

  – It’s Typically Done in a Medical Setting: Many ketamine treatments, especially those for mental health conditions, are done in controlled environments like clinics or hospitals. This allows for careful monitoring during and after the treatment, ensuring your safety and well-being.

– Discuss Your Treatment Plan: Talk to your doctor about what to expect from ketamine therapy, including the number of treatments, the dosage, and any potential side effects. Make sure to discuss other medications you’re taking and your overall health to avoid any complications.

Conclusion

Ketamine’s status as a Schedule III controlled substance reflects its dual nature as both a valuable medical treatment and a drug with the potential for misuse. For patients, this means access to ketamine is regulated and its use is carefully monitored by healthcare professionals. While the regulations might seem stringent, they are in place to protect your health and ensure that ketamine is used in a safe, effective manner.

If you’re exploring ketamine as a treatment option, it’s essential to work with a qualified healthcare provider who can guide you through the process and ensure that the therapy is tailored to your needs.